Results 21 to 30 of about 14,390 (160)

Vitamin D attenuates cardiac hypertrophy in rats through mRNA regulation of interleukin-6 and its receptor

open access: yesResearch in Cardiovascular Medicine, 2023
Context: Interleukin-6 (IL-6), a pro-inflammatory cytokine, plays an important role in the pathogenesis of myocardial hypertrophy. By integrating its membrane receptor complex (gp80), IL-6 activates the signal guidance components (gp130) and activates ...
Ahad Nikkholgh   +3 more
doaj   +1 more source

Roads to Stat3 Paved with Cadherins

open access: yesCells, 2022
The engagement of cadherins, cell-to-cell adhesion proteins, triggers a dramatic increase in the levels and activity of the Rac/Cdc42 GTPases, through the inhibition of proteasomal degradation.
Hanad Adan, Juliet Daniel, Leda Raptis
doaj   +1 more source

gp130 Controls Cardiomyocyte Proliferation and Heart Regeneration [PDF]

open access: yesCirculation, 2020
Background: A key cause of the high mortality of cardiovascular diseases is the cardiomyocyte inability to renew after cardiac injury. As a promising strategy to supplement functional myocytes for cardiac repair, there is a pressing need to understand the cellular and molecular mechanisms of heart regeneration.
Yandong Li   +11 more
openaire   +2 more sources

Cross-talk among gp130 Cytokines in Adipocytes [PDF]

open access: yesJournal of Biological Chemistry, 2005
The interleukin-6 (IL-6) family of cytokines is a family of structurally and functionally related proteins, including IL-6, IL-11, leukemia inhibitory factor (LIF), oncostatin M (OSM), ciliary neurotrophic factor (CNTF), and cardiotrophin-1 (CT-1). These proteins are also known as gp130 cytokines because they all share gp130 as a common transducer ...
Sanjin, Zvonic   +4 more
openaire   +2 more sources

GP130 Cytokines in Breast Cancer and Bone [PDF]

open access: yesCancers, 2020
Breast cancer cells have a high predilection for skeletal homing, where they may either induce osteolytic bone destruction or enter a latency period in which they remain quiescent. Breast cancer cells produce and encounter autocrine and paracrine cytokine signals in the bone microenvironment, which can influence their behavior in multiple ways.
Tolu Omokehinde, Rachelle W. Johnson
openaire   +2 more sources

Differing Outcome of Experimental Autoimmune Encephalitis in Macrophage/Neutrophil- and T Cell-Specific gp130-Deficient Mice

open access: yesFrontiers in Immunology, 2018
gp130 cytokines are differentially involved in regulating the T helper (H) 17-driven pathogenesis of experimental autoimmune encephalomyelitis (EAE), the animal model of human multiple sclerosis.
Kristian Holz   +11 more
doaj   +1 more source

Sepsis induces interleukin 6, gp130/JAK2/STAT3, and muscle wasting

open access: yesJournal of Cachexia, Sarcopenia and Muscle, 2022
Background Sepsis and inflammation can cause intensive care unit‐acquired weakness (ICUAW). Increased interleukin‐6 (IL‐6) plasma levels are a risk factor for ICUAW. IL‐6 signalling involves the glycoprotein 130 (gp130) receptor and the JAK/STAT‐pathway,
Lukas Zanders   +13 more
doaj   +1 more source

CD9 exacerbates pathological cardiac hypertrophy through regulating GP130/STAT3 signaling pathway

open access: yesiScience, 2023
Summary: CD9 is a member of the tetraspanin protein family, which has been widely studied in inflammation and cancer, but not in pathological cardiac hypertrophy.
Yue Li   +12 more
doaj   +1 more source

Signaling Through gp130 Compromises Suppressive Function in Human FOXP3+ Regulatory T Cells

open access: yesFrontiers in Immunology, 2019
The CD4+FOXP3+ regulatory T cell (Treg) subset is an indispensable mediator of immune tolerance. While high and stable expression of the transcription factor FOXP3 is considered a hallmark feature of Treg cells, our previous studies have demonstrated ...
Khalid Bin Dhuban   +9 more
doaj   +1 more source

The role of cytokines in ovarian cancer drug resistance. [PDF]

open access: yesInt J Cancer
Abstract Ovarian cancer is the leading cause of death among women diagnosed with female reproductive system cancers. While significant advances have been made in treating various types of cancer, progress in ovarian cancer treatment over the past 20 years has been minimal, and the treatment course of ovarian cancer is not linear. Although many patients
Wang L   +7 more
europepmc   +2 more sources

Home - About - Disclaimer - Privacy